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Résumé en
anglais
Bacterial infections are mostly due to bacteria in their biofilm-mode of growth, while
penetrability of antimicrobials into infectious biofilms and increasing antibiotic
resistance hamper infection treatment. In-vitro, monolaurin lipid nanocapsules (ML-
LNCs) carrying adsorbed antimicrobial peptides (AMPs) displayed synergistic efficacy
against planktonic Staphylococcus aureus, but it has not been demonstrated, neither
in-vitro nor in-vivo, that such ML-LNCs penetrate into infectious S. aureus biofilms and
maintain synergy with AMPs. This study investigates the release mechanism of AMPs
from ML-LNCs and possible antimicrobial synergy of ML-LNCs with the AMPs DPK-060
and LL-37 against S. aureus biofilms in-vitro and in a therapeutic, murine, infected
wound-healing model. Zeta potentials demonstrated that AMP release from ML-LNCs
was controlled by the AMP concentration in suspension. Both AMPs demonstrated no
antimicrobial efficacy against four staphylococcal strains in a planktonic mode, while a
checkerboard assay showed synergistic antimicrobial efficacy when ML-LNCs and
DPK-060 were combined, but not for combinations of ML-LNCs and LL-37. Similar
effects were seen for growth reduction of staphylococcal biofilms, with antimicrobial
synergy persisting only for ML-LNCs at the highest level of DPK-060 or LL-37
adsorption. Healing of wounds infected with bioluminescent S. aureus Xen36, treated
with ML-LNCs alone, was faster when treated with PBS, while AMPs alone did not
yield faster wound-healing than PBS. Faster, synergistic wound-healing due to ML-
LNCs with adsorbed DPK-060, was absent in-vivo. Summarizing, antimicrobial synergy
of ML-LNCs with adsorbed antimicrobial peptides as seen in-vitro, is absent in in-vivo
healing of infected wounds, likely because host AMPs adapted the synergistic role of
the AMPs added. Thus, conclusions regarding synergistic antimicrobial efficacy, should
not be drawn from planktonic data, while even in-vitro biofilm data bear little
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